UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program vs Tempus ECG-AF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program

by Canon Medical Systems Corporation

Tempus ECG-AF

by Tempus AI, Inc.

AI Verdict

Tool A is an AI-enabled program for advanced cardiac motion tracking and measurement from ultrasound images, designed for detailed offline analysis and procedure planning. In contrast, Tool B is an AI-based algorithm that analyzes 12-lead ECG recordings to identify patients at increased risk of developing atrial fibrillation. While both fall under Cardiology AI, their distinct input modalities (ultrasound vs. ECG) and primary clinical applications (detailed structural/functional analysis vs. arrhythmia risk prediction) make them adjacent rather than direct competitors.

Choose UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program if…

Choose UltraExtend NX CUW-U001S V2.0 if your primary need is advanced, quantitative analysis of cardiac ultrasound images for diagnosis, monitoring, and procedural planning. This program is ideal for physicians requiring precise measurements of cardiac motion, wall tracking, and ejection fraction from 2D and 3D data, facilitating detailed post-processing and planning of complex procedures like THV deployment. Its comprehensive offline workflow supports in-depth review, analysis, and reporting.

View UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program →

Choose Tempus ECG-AF if…

Choose Tempus ECG-AF if your objective is to proactively identify patients aged 65 or older at increased risk of developing new-onset atrial fibrillation within the next 12 months. This AI-based algorithm is specifically designed to analyze 12-lead ECG recordings to support earlier identification and follow-up for this vulnerable population, enabling timely interventions to potentially mitigate future cardiac events.

View Tempus ECG-AF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program	Tempus ECG-AF
Pricing	Unknown	Contact vendor
Deployment	On-premise (software application)	Software solution, integrated into healthcare facility systems with advanced cardiology algorithms.
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program	Tempus ECG-AF
Name	UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program	Tempus ECG-AF
Company	Canon Medical Systems Corporation	Tempus AI, Inc.
Description	AI-enabled ultrasound image analysis program for advanced cardiac motion tracking and measurement, facilitating offline analysis and optimizing workflow.	AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.
Key Functionality	AI-enabled advanced cardiac motion tracking and measurement, 2D and 3D Wall Motion Tracking, Auto EF LV, post-processing analysis of ultrasound images, complete offline workflow.	AI-based algorithm for 12-lead ECG analysis, detects signs associated with new onset Atrial Fibrillation (AF) within 12 months for patients 65 years or older.
Target Patient Population	Not specified	Patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery.

Videos

Demos, reviews, and walkthroughs featuring UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program and Tempus ECG-AF.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical application of each tool?

UltraExtend NX CUW-U001S V2.0 is an AI-enabled ultrasound image analysis program for advanced cardiac motion tracking, measurement, and post-processing of ultrasound images to optimize workflow and plan complex procedures. Tempus ECG-AF is an AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.

What type of patient data does each tool analyze?

UltraExtend NX CUW-U001S V2.0 analyzes 2D and 3D ultrasound images, including 3D TEE data, for post-processing analysis. Tempus ECG-AF analyzes 12-lead ECG recordings.

Are there specific patient populations each tool is designed for?

UltraExtend NX CUW-U001S V2.0 is intended for physicians in hospital and clinical settings for cardiac analysis and procedure planning. Tempus ECG-AF is specifically for patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery.

What are the key outputs or insights provided by each tool?

UltraExtend NX CUW-U001S V2.0 provides AI-enabled advanced cardiac motion tracking and measurement, 2D and 3D Wall Motion Tracking, Auto EF LV, and precise/reproducible cardiac quantification. Tempus ECG-AF identifies signs associated with new onset Atrial Fibrillation (AF) within 12 months for eligible patients.

Is there any specific reimbursement information available for either tool?

For UltraExtend NX CUW-U001S V2.0, pricing requires contacting the vendor, and no specific reimbursement information is provided. For Tempus ECG-AF, CMS reimbursement is available with CPT codes 0764T and 0765T to APC 5734, with a Medicare rate of $128.90, effective January 1, 2025.

What are the compatibility requirements for each tool?

UltraExtend NX CUW-U001S V2.0 leverages Canon's raw data architecture and is compatible with Aplio i- and a-series diagnostic ultrasound systems. Tempus ECG-AF is compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program or Tempus ECG-AF

Backers

Who funded each tool's parent company.